Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Sep 27, 2014; 6(9): 660-669
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.660
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.660
Figure 2 Diagnostic value of liver stiffness measurement to predict sustained virological response.
The area under the receiver operating characteristic curve was 0.64 (0.52-0.76).
- Citation: Bonnet D, Guivarch M, Bérard E, Combis JM, Remy AJ, Glibert A, Payen JL, Metivier S, Barange K, Desmorat H, Palacin A, Nicot F, Abravanel F, Alric L. Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients. World J Hepatol 2014; 6(9): 660-669
- URL: https://www.wjgnet.com/1948-5182/full/v6/i9/660.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i9.660